oncology
1,857 projects
breast cancer168leukemia137skin cancer106prostate cancer99colorectal cancer78lung cancer67pancreatic cancer42liver cancer37cervical cancer10bladder cancer10head and neck cancer7
FP7Reintegration grant2013–2017Türkiye
TRIGBM · Identification of TRAIL sensitivity/resistance mechanisms and searching for novel TRAIL-sensitizing agents in Glioblastoma Multiforme
FP7Reintegration grant2013–2017Netherlands
BLADDER CANCER EPID · Nutrition and Bladder Cancer
FP7Reintegration grant2013–2017Belgium
METABOLISMCONNECT · Can metabolic states induced by diabetes and obesity promote cancer?
FP7Staff exchange2013–2017Spain
AIDPATH · Academia and Industry Collaboration for Digital Pathology
11 partners · 8 countries
FP7Reintegration grant2013–2017France
LSD1 IMPACT · Dissecting the interaction network of the histone demethylase LSD1 in vivo
FP7Reintegration grant2013–2017France
PRONO · Notch and epithelial proliferation
FP7Reintegration grant2013–2017United Kingdom
SERPLUC · Suppression of Enzymes Required for Progression of LUng Cancer
FP7Reintegration grant2013–2017Israel
SMURF2 IN CANCER · Molecular mechanisms of tumor suppressor functions of HECT-type E3 ligase Smurf2: roles in chromatin organization, dynamics, gene expression and DNA damage response and repair
FP7Reintegration grant2013–2017Spain
GLYCODRUGS · new strategies for controlling the activity of glycosidase enzymes and their application in therapies for lysosomal storage diseases and cancer
FP7Individual fellowship2013–2015Sweden
NCAT · Nudix hydrolases in Cancer Therapy
FP7Individual fellowship2013–2015United Kingdom
ImageMelTherapyLRI · Single cell level intravital imaging of response, tolerance, and resistance to targeted therapies
2 partners
FP7Individual fellowship2013–2015France
MKlp2-mitosis · MKlp2 - a mitotic kinesin and a prime target for cancer therapy
FP7Reintegration grant2013–2017Austria
BERG · Biomedical Epigenomics Research Group
FP7Reintegration grant2013–2017Israel
HSCSPECDDR · Elucidation of DNA Damage Response mechanisms in human normal and leukemia stem cells
FP7Reintegration grant2013–2017Germany
BONEMETTNC · Analysis of Tenascin C function in breast cancer metastasis to bone
FP7Reintegration grant2013–2017Spain
PRR IN IMMUNOTHERAPY · COMBINATIONAL USE OF INNATE IMMUNE RECEPTORS FOR CANCER IMMUNOTHERAPY
FP7Individual fellowship2013–2015Austria
BB: DICJI · Breaking barriers: Investigating the junctional and mechanobiological changes underlying the ability of Drosophila immune cells to invade an epithelium
FP7Individual fellowship2013–2015France
SMPHS · Improved Statistical Monitoring Procedures for Attributes with Applications in Public Health Surveillance
FP7Reintegration grant2013–2017United Kingdom
TAMIRCRT · Targeting microRNAs for ColoRectal Cancer Therapy
2 partners
FP7Individual fellowship2013–2015Norway
HYPERTAM · Evaluation of the synergy between tamoxifen chemotherapy and hypericin photodynamic action, following mitochondrial complex III photo-inhibition: Towards a combinatorial anticancer treatment modality
FP7Individual fellowship2013–2015Netherlands
GENE · Genomic screening of the Embryo for Novel targets in the tumor Endothelium
FP7Reintegration grant2013–2017Spain
PERSMEDOMICS · Bioinformatics and Integrative Genomics for a Novel Personalized Cancer Therapy
FP7Reintegration grant2013–2016Belgium
CHAMELEO · Cellular Hypoxia Alters DNA Methylation through Loss of Epigenome Oxidation
FP7Individual fellowship2013–2015United Kingdom
BLMCOMPLEX · Mechanism of Holliday junction dissolution by the Bloom’s Syndrome complex
2 partners